Search results

Evidence-based recommendations on using Intrabeam radiotherapy during breast-conserving surgery in adults.

Result type

Technology appraisal guidance

Published

31 January 2018

Evidence-based recommendations on mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma in adults.

Result type

Technology appraisal guidance

Published

31 May 2023

Biographies for each member of the highly specialised technologies evaluation committee.

Biographies for each member of the highly specialised technologies evaluation committee.

Early value assessment (EVA) guidance on artificial intelligence (AI) technologies to aid opportunistic detection of vertebral fragility fractures.

Result type

HealthTech guidance

Published

14 October 2025

Evidence-based recommendations on maximal cytoreductive surgery for advanced ovarian cancer. This involves removing all or almost all visible cancerous tissue. More tissue is removed than with standard surgery. The aim is to improve outcomes for people with advanced ovarian cancer.

Result type

HealthTech guidance

Published

5 April 2023

Evidence-based recommendations on pegaspargase (Oncaspar) for treating acute lymphoblastic leukaemia.

Result type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for treating intermittent claudication in adults with peripheral arterial disease.

Result type

Technology appraisal guidance

Published

25 May 2011

NICE has developed a Medtech Innovation Briefing (MIB) on Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds

Result type

Medtech innovation briefing

Published

19 November 2014

Evidence-based recommendations on pertuzumab (Perjeta) for adjuvant treatment of HER2-positive early stage breast cancer in adults.

Result type

Technology appraisal guidance

Published

20 March 2019

NICE has developed a medtech innovation briefing (MIB) on Permacol for treating anal fistulae .

Result type

Medtech innovation briefing

Published

23 May 2017

Evidence-based recommendations on abemaciclib (Verzenios) with fulvestrant for hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy in adults.

Result type

Technology appraisal guidance

Published

15 September 2021

Evidence-based recommendations on inclisiran (Leqvio) for treating primary hypercholesterolaemia or mixed dyslipidaemia in adults.

Result type

Technology appraisal guidance

Published

6 October 2021

Evidence-based recommendations on bevacizumab (Avastin) and cetuximab (Erbitux) for treating metastatic colorectal cancer in adults.

Result type

Technology appraisal guidance

Last updated

1 January 2012

This guideline covers care and support for adults with cerebral palsy. It aims to improve health and wellbeing, promote access to services and support participation and independent living.

Result type

NICE guideline

Published

15 January 2019